Explore the importance of histology and biomarker evaluation for oncology clinical trials.
Clinical trials are integral to the development of new cancer treatments. Researchers conducting oncology-focused clinical trials frequently use diagnostic tools such as histology to analyze samples and generate data. They use this information to identify novel biomarkers or new potential therapeutic agents. As such, diagnostic laboratories play a critical role in clinical trial data integrity.
Download this white paper from Canopy Biosciences to explore the importance of choosing the right laboratory for clinical and pre-clinical drug development research.
